Loading... Please wait...

Xenon Pharmaceuticals Inc. (XENE) Ownership

Currency in USD Disclaimer
$37.49 $0.68 (1.84%)
$37.01
$37.6
$27.99
$50.99
  • RECENT QUARTER TOTAL INVESTED

    $3.16 B

      -$254.17 M

  • RECENT QUARTER INSTITUTIONAL OWNERSHIP PERCENTAGE

    109.77%

      0.68%

  • TOTAL INVESTED OF LAST QUARTER

    $3.42 B
  • OWNERSHIP PERCENTAGE OF LAST QUARTER

    109.09%
*Showing results of the last quarter update.

Xenon Pharmaceuticals Inc. Major Shareholders & Ownership History


Reporting Date Major Shareholder Name Shares Held Market Value Change in Shares Ownership
05/13/2024 FMR LLC 6.60 M $284.21 M   16.72% 9.87%
05/15/2024 AVORO CAPITAL ADVISORS LLC 5.67 M $243.95 M   0.00% 8.47%
05/15/2024 DRIEHAUS CAPITAL MANAGEMENT LLC 4.32 M $186.05 M   -0.54% 6.46%
05/15/2024 WELLINGTON MANAGEMENT GROUP LLP 3.92 M $168.84 M   -5.78% 5.86%
05/14/2024 CAPITAL WORLD INVESTORS 2.68 M $115.44 M   0.00% 4.01%
05/15/2024 POLAR CAPITAL HOLDINGS PLC 2.61 M $112.45 M   -14.82% 3.91%
05/15/2024 PARADIGM BIOCAPITAL ADVISORS LP 2.48 M $106.97 M   16.80% 3.71%
05/14/2024 CAPITAL INTERNATIONAL INVESTORS 2.48 M $106.59 M   0.82% 3.70%
05/15/2024 COMMODORE CAPITAL LP 2.17 M $93.32 M   0.00% 3.24%
05/10/2024 BLACKROCK INC. 2.12 M $91.35 M   2.65% 3.17%
05/15/2024 ADAGE CAPITAL PARTNERS GP, L.L.C. 1.67 M $71.98 M   59.42% 2.50%
05/14/2024 PICTET ASSET MANAGEMENT HOLDING SA 1.52 M $65.24 M   -25.73% 2.27%
05/14/2024 ALLIANCEBERNSTEIN L.P. 1.47 M $63.22 M   -6.74% 2.20%
05/15/2024 MARSHALL WACE, LLP 1.45 M $62.44 M   -5.12% 2.17%
05/15/2024 T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 1.43 M $61.40 M   60.06% 2.13%
05/15/2024 FIRST LIGHT ASSET MANAGEMENT, LLC 1.32 M $56.83 M   -19.77% 1.97%
05/15/2024 BRAIDWELL LP 1.31 M $56.31 M   -20.60% 1.96%
05/15/2024 CITADEL ADVISORS LLC 1.29 M $55.41 M   1.60% 1.92%
05/15/2024 ROCK SPRINGS CAPITAL MANAGEMENT LP 1.26 M $54.05 M   0.00% 1.88%
05/14/2024 INVESCO LTD. 1.05 M $45.18 M   45.82% 1.57%
05/15/2024 BAKER BROS. ADVISORS LP 993,679 $42.78 M   0.00% 1.49%
05/15/2024 JANUS HENDERSON GROUP PLC 941,569 $40.55 M   -2.54% 1.41%
05/09/2024 LORD, ABBETT & CO. LLC 895,196 $38.54 M   24.68% 1.34%
05/15/2024 PERCEPTIVE ADVISORS LLC 892,208 $38.41 M   -18.95% 1.33%
05/14/2024 AFFINITY ASSET ADVISORS, LLC 837,387 $36.05 M   82.04% 1.25%
05/07/2024 TIMESSQUARE CAPITAL MANAGEMENT, LLC 737,173 $31.74 M   -7.15% 1.10%
05/14/2024 FEDERATED HERMES, INC. 734,900 $31.64 M   112.03% 1.10%
05/15/2024 AVIDITY PARTNERS MANAGEMENT LP 710,000 $30.57 M   -12.99% 1.06%
05/14/2024 LOOMIS SAYLES & CO L P 686,510 $29.55 M   -3.08% 1.03%
05/06/2024 FIRST TURN MANAGEMENT, LLC 680,389 $29.29 M   0.00% 1.02%
05/15/2024 BOXER CAPITAL, LLC 600,000 $25.83 M   0.00% 0.90%
05/01/2024 FIERA CAPITAL CORP 576,542 $24.82 M   4.25% 0.86%
05/02/2024 JENNISON ASSOCIATES LLC 563,952 $24.28 M   -0.43% 0.84%
05/06/2024 CANDRIAM S.C.A. 560,884 $24.15 M   5.65% 0.84%
05/15/2024 ORBIMED ADVISORS LLC 550,000 $23.68 M   0.00% 0.82%
05/13/2024 FRANKLIN RESOURCES INC 542,289 $23.35 M   84.56% 0.81%
05/15/2024 GREAT POINT PARTNERS LLC 456,148 $19.64 M   -23.98% 0.68%
05/08/2024 BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 416,736 $17.94 M   100.00% 0.62%
05/10/2024 DIMENSIONAL FUND ADVISORS LP 410,207 $17.66 M   1.87% 0.61%
05/14/2024 VESTAL POINT CAPITAL, LP 400,000 $17.22 M   128.57% 0.60%
05/15/2024 SAMLYN CAPITAL, LLC 396,196 $17.06 M   -5.93% 0.59%
05/15/2024 MORGAN STANLEY 386,199 $16.63 M   71.53% 0.58%
05/15/2024 ALTIUM CAPITAL MANAGEMENT LP 348,000 $14.98 M   19.78% 0.52%
05/10/2024 WESTFIELD CAPITAL MANAGEMENT CO LP 347,351 $14.95 M   46.26% 0.52%
05/10/2024 VANGUARD GROUP INC 335,635 $14.45 M   3.75% 0.50%
05/15/2024 ALLY BRIDGE GROUP (NY) LLC 309,369 $13.32 M   27.86% 0.46%
05/15/2024 GOLDMAN SACHS GROUP INC 299,774 $12.91 M   -20.34% 0.45%
05/15/2024 BOONE CAPITAL MANAGEMENT LLC 291,403 $12.54 M   14.08% 0.44%
05/15/2024 POINT72 ASSET MANAGEMENT, L.P. 275,859 $11.88 M   -68.48% 0.41%
05/15/2024 TWO SIGMA INVESTMENTS, LP 274,626 $11.82 M   -19.23% 0.41%

Xenon Pharmaceuticals Inc. institutional Ownership - Frequently Asked Questions

  • Q. Who are the largest shareholders of XENE shares?

    A. During the previous two years, 262 institutional investors and hedge funds held shares of Xenon Pharmaceuticals Inc.. The most heavily invested institutionals were:

    FMR LLC: 6.6 M

    Avoro Capital Advisors LLC: 5.67 M

    DRIEHAUS CAPITAL MANAGEMENT LLC: 4.32 M

    WELLINGTON MANAGEMENT GROUP LLP: 3.92 M

    Capital World Investors: 2.68 M

    Polar Capital Holdings Plc: 2.61 M

  • Q. What percentage of Xenon Pharmaceuticals Inc. stock is owned by institutional investors?

    A. 109.77% of Xenon Pharmaceuticals Inc. stock is owned by institutional investors.

  • Q. How much institutional buying is happening at XENE ?

    A. Institutional investors have bought a total of 84.66 M shares in the last 24 months. This purchase volume represents approximately $3.17 B in transactions.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.